ETFs with ABT as a Top 10 Holding*Sponsored by:
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|6.03%||iShares Dow Jones U.S. Pharmaceutical Index Fund (IHE)||+12.92 (14.28%)|
|5.89%||Select Sector SPDR Fund - Health Care (XLV)||+2.17 (5.63%)|
|5.62%||Vanguard Health Care ETF (VHT)||+11.93 (15.57%)|
|5.04%||PowerShares Dynamic Pharmaceuticals (PJP)||+6.77 (18.44%)|
|4.62%||Merrill Lynch Pharmaceutical HOLDRS (PPH)||+5.21 (12.35%)|
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott's* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products. FINANCIAL INFORMATION RELATING TO INDUSTRY SEGMENTS, GEOGRAPHIC AREAS, AND CLASSES OF SIMILAR PRODUCTS Incorporated herein by reference is Note 6 entitled "Segment and Geographic Area Information" of the Notes to Consolidated Financial Statements included under Item 8, "Financial Statements and Supplementary Data" and the sales information related to HUMIRA® included in "Financial Review." NARRATIVE DESCRIPTION OF BUSINESS Through December 31, 2012, Abbott had five reportable revenue segments: Proprietary Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. ... More ...